Werewolf Therapeutics (HOWL) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.43
-0.29
-0.14
0

Details

Expected EPS
-0.37608
Actual EPS
-0.43
Surprise EPS
-0.05
Surprise Percent
+14.34%

Description

Werewolf Therapeutics (HOWL) has reported earnings of -0.43 per share for Q3 2024.

0 Comments

Share your thoughts